InflaRx NV (IFRX)
1.61
+0.16
(+11.03%)
USD |
NASDAQ |
May 17, 16:00
1.61
0.00 (0.00%)
After-Hours: 20:00
InflaRx Gross Profit Margin (Quarterly): -511.9% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -511.9% |
December 31, 2023 | -12.02K% |
Date | Value |
---|---|
September 30, 2023 | -319.6% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-12.02K%
Minimum
Dec 2023
-319.6%
Maximum
Sep 2023
-4.28K%
Average
-511.9%
Median
Mar 2024
Gross Profit Margin (Quarterly) Benchmarks
Affimed NV | -- |
MorphoSys AG | 75.20% |
BioNTech SE | 68.50% |
Immatics NV | -- |
CureVac NV | -137.5% |
Gross Profit Margin (Quarterly) Related Metrics
Profit Margin (Quarterly) | -26.80K% |
Operating Margin (Quarterly) | -34.66K% |